{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T17:20:57Z","timestamp":1772904057233,"version":"3.50.1"},"reference-count":30,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sex Transm Infect"],"accepted":{"date-parts":[[2011,10,11]]},"published-print":{"date-parts":[[2012,4]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Genital tract infections caused by<jats:italic>Neisseria gonorrhoeae<\/jats:italic>are a major cause of sexually transmitted disease worldwide. Surveillance data suggest that incidence has increased in recent years after initially falling in the face of intensified control efforts.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>The authors sought to evaluate the potential contribution of antimicrobial resistance to such rebound and to identify optimal treatment strategies in the face of resistance using a mathematical model of gonorrhoea.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The authors built risk-structured \u2018susceptible\u2013infectious\u2013susceptible\u2019 models with and without the possibility of antibiotic resistance and used these models as a platform for the evaluation of competing plausible treatment strategies, including changing antimicrobial choice when resistance prevalence surpassed fixed thresholds, random assignment of treatment and use of combination antimicrobial therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Absent antimicrobial resistance, strategies that focus on treatment of highest risk individuals (the so-called core group) result in collapse of disease transmission. When antimicrobial resistance exists, a focus on the core group causes rebound in incidence, with maximal dissemination of antibiotic resistance. Random assignment of antimicrobial treatment class outperformed the use of fixed resistance thresholds with respect to sustained reduction in gonorrhoea prevalence.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Gonorrhoea control is achievable only when core groups are treated, but treatment of core groups maximises dissemination of antimicrobial-resistant strains. This paradox poses a great dilemma to the control and prevention of gonorrhoea and underlines the need for gonococcal vaccines.<\/jats:p><\/jats:sec>","DOI":"10.1136\/sextrans-2011-050049","type":"journal-article","created":{"date-parts":[[2011,12,15]],"date-time":"2011-12-15T06:01:25Z","timestamp":1323928885000},"page":"200-204","source":"Crossref","is-referenced-by-count":46,"title":["Core groups, antimicrobial resistance and rebound in gonorrhoea in North America"],"prefix":"10.1136","volume":"88","author":[{"given":"Christina H","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin J","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David N","family":"Fisman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2011,12,14]]},"reference":[{"key":"2024051319023763000_88.3.200.1","doi-asserted-by":"publisher","DOI":"10.1136\/sti.75.1.3"},{"key":"2024051319023763000_88.3.200.2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-74-6-979"},{"key":"2024051319023763000_88.3.200.3","first-page":"151","article-title":"Gonorrhea: epidemiology and control strategies","volume":"6","author":"Alary","year":"1997","journal-title":"CJHS"},{"key":"2024051319023763000_88.3.200.4","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/00007435-199808000-00011","article-title":"Gonorrhea in the United States, 1981-1996. Demographic and geographic trends","volume":"25","author":"Fox","year":"1998","journal-title":"Sex Transm Dis"},{"key":"2024051319023763000_88.3.200.5","first-page":"1","article-title":"Gonorrhea transmission dynamics and control","volume":"56","author":"Hethecote","year":"1985","journal-title":"Lect Notes Biomath"},{"key":"2024051319023763000_88.3.200.6","unstructured":"Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2008. Atlanta, GA: U.S. Department of Health and Human Services, 2009."},{"key":"2024051319023763000_88.3.200.7","unstructured":"Jayaraman GC Totten S Perrin M . Report on Sexually Transmitted Infections in Canada: 2008. Ottawa: Public Health Agency of Canada, 2010."},{"key":"2024051319023763000_88.3.200.8","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.080222"},{"key":"2024051319023763000_88.3.200.9","unstructured":"Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2007 Supplement, Gonococcal Isolate Surveillance Project (GISP) Annual Report 2007. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2009."},{"key":"2024051319023763000_88.3.200.10","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-007-0024-7"},{"key":"2024051319023763000_88.3.200.11","unstructured":"Tapsall J . Antimicrobial resistance in Neisseria gonorrhoeae. Sydney, Australia: World Health Organization, 2001."},{"key":"2024051319023763000_88.3.200.12","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-148-8-200804150-00005"},{"key":"2024051319023763000_88.3.200.13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.22.12106"},{"key":"2024051319023763000_88.3.200.14","doi-asserted-by":"publisher","DOI":"10.1086\/522964"},{"key":"2024051319023763000_88.3.200.15","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318165dc0b"},{"key":"2024051319023763000_88.3.200.16","unstructured":"Anderson RM May RM . Infectious Disease of Humans: Dynamics and Control. New York: Oxford University Press, 1992."},{"key":"2024051319023763000_88.3.200.17","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2008.029850"},{"key":"2024051319023763000_88.3.200.18","unstructured":"Brown WJ Donohue JF Axnick NW . Gonorrhea. Syphilis and Other Venereal Diseases. Cambridge, Massachusetts: Harvard University Press, 1970:82\u201397."},{"key":"2024051319023763000_88.3.200.19","unstructured":"Public Health Agency of Canada. 1998\/1999 Canadian sexually transmitted diseases (STD) surveillance report. In: Control DoSPa , ed. Canada Communicable Disease Report. Ottawa, ON: Health Canada, 2000:36."},{"key":"2024051319023763000_88.3.200.20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.6.726"},{"key":"2024051319023763000_88.3.200.21","first-page":"335","article-title":"Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men\u2013United States, 2003, and revised recommendations for gonorrhea treatment, 2004","volume":"53","author":"Centers for Disease Control and Prevention","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1 Suppl 1","key":"2024051319023763000_88.3.200.22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bbmt.2005.10.004","article-title":"Bionanotechnology progress and advances","volume":"12","author":"Chan","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"2024051319023763000_88.3.200.23","doi-asserted-by":"crossref","unstructured":"Cohen DR Henderson JB . Preventive Behaviour: A Closer Look. Health, Prevention and Economics. New York: Oxford University Press, 1988:114\u201332.","DOI":"10.1093\/oso\/9780192621665.003.0009"},{"key":"2024051319023763000_88.3.200.24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1155\/2010\/602510","article-title":"New antibacterials?","volume":"21","author":"Laupland","year":"2010","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"2024051319023763000_88.3.200.25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.4.447"},{"key":"2024051319023763000_88.3.200.26","first-page":"1052","article-title":"Notice to readers: discontinuation of cefixime tablets\u2014United States","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024051319023763000_88.3.200.27","doi-asserted-by":"crossref","unstructured":"Sparling PF . Biology of Neisseria gonorrhoeae . In: Holmes KK Sparling PF Mardh PA , eds. Sexually Transmitted Diseases. New York: McGraw-Hill, 1999.","DOI":"10.1385\/0896035352"},{"key":"2024051319023763000_88.3.200.28","first-page":"454","article-title":"Effectiveness of condoms in preventing sexually transmitted infections","volume":"82","author":"Holmes","year":"2004","journal-title":"Bull World Health Organ"},{"key":"2024051319023763000_88.3.200.29","unstructured":"Sepkowitz KA . Ideas & trends; the antidote is still whispered. The New York Times. 7 July 2002. http:\/\/nyti.ms\/rYXGml."},{"key":"2024051319023763000_88.3.200.30","unstructured":"Hook E III Handsfield H . Gonococcal infections in the adult. In: Holmes KK Sparling PF Mardh PA , eds. Sexually Transmitted Diseases: McGraw-Hill, 1999."}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2011-050049","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T02:03:22Z","timestamp":1715652202000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2011-050049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,14]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,3,13]]},"published-print":{"date-parts":[[2012,4]]}},"alternative-id":["10.1136\/sextrans-2011-050049"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2011-050049","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,14]]}}}